MEDINDIA

Search Medindia

Press Releases

Health News Posted on Tuesday, December 9, 2025

Premium Press Releases »

Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America

ADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new  Diversity in STEM Scholarships , a global initiative designed to support women and ...

Read More

Geneva College of Longevity Science and DrVibe.ai Launch the GCLS AI Academy for Longevity Sciences

New Website:  https://gcls.ai GENEVA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) , in partnership with DrVibe.ai , today announced the launch of the GCLS AI Academy for Longevity Sciences —the ...

Read More

CLINUVEL Expands Singapore RD&I Centre to Pioneer Next-generation Peptide Therapies

EXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery platforms existing RD&I teams will advance ...

Read More

Press Releases »

Saol Therapeutics Has Been Granted a Type A Meeting with the FDA to Determine the Path Forward for SL1009 in Pyruvate Dehydrogenase Complex Deficiency (PDCD)

PR Newswire ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Dec. 9, 2025 FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an ...

Read More

American Lung Association Launches Campaign to Help New England Residents Stay Healthy This Winter

PR Newswire CHICAGO, Dec. 9, 2025 New campaign educates adults about vaccines that protect against flu, COVID-19 and RSV CHICAGO, Dec. 9, 2025 /PRNewswire/ -- Each winter, too many families across New England are impacted by respiratory ...

Read More

Exercise Might Help Improve Mobility During Aging

PR Newswire NEW YORK, Dec. 9, 2025 Study Findings May Provide Key Insight into Parkinson's Disease NEW YORK, Dec. 9, 2025 /PRNewswire/ -- The brain-chemical surge that comes with running may bolster coordination and speed in the old and ...

Read More

REVEALED: SKINCARE WOMEN NEGLECT DURING THE HOLIDAY SEASON, NEW RESEARCH FROM TENA

PR Newswire PHILADELPHIA, Dec. 9, 2025 PHILADELPHIA, Dec. 9, 2025 /PRNewswire/ -- As the festive season approaches and Americans prepare for weeks of holiday parties, colder weather and gift-shopping marathons, new research from TENA, the ...

Read More

Sweden Recommends: A Dose of Northern Lights Therapy

PR Newswire STOCKHOLM, Dec. 9, 2025 STOCKHOLM, Dec. 9, 2025 /PRNewswire/ -- As the world's first country to be prescribed for its health benefits, Sweden is now shining a light on one of its most awe-inducing wellness experiences. Aurora ...

Read More

Phase II Data of Cadonilimab Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer Presented at ESMO Asia 2025

PR Newswire HONG KONG, Dec. 9, 2025 HONG KONG, Dec. 9, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that data from the Phase II study (COMPASSION-25) for its first-in-class PD-1/CTLA-4 bispecific antibody, ...

Read More

GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy

PR Newswire YONGIN, South Korea, Dec. 9, 2025 YONGIN, South Korea, Dec. 9, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) fragmentation patterns ...

Read More

Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)

PR Newswire GOTHENBURG, Sweden, Dec. 8, 2025 GOTHENBURG, Sweden, Dec. 8, 2025 /PRNewswire/ -- Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare ...

Read More

Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US

PR Newswire LONDON, Dec. 8, 2025 Ready-to-use sepsis therapy marks new advancement in time-critical treatment LONDON, Dec. 8, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today ...

Read More

Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study

PR Newswire CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Dec. 8, 2025 Consistent and robust efficacy demonstrated across bleed types, locations, and dose cohorts The weekly dosing cohort achieved an estimated 87% reduction in annualized ...

Read More

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

PR Newswire FLORENCE, Italy and NEW YORK, Dec. 8, 2025 FLORENCE, Italy and NEW YORK, Dec. 8, 2025 /PRNewswire/ -- The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...

Read More

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

PR Newswire PROVIDENCE, R.I., Dec. 8, 2025 PROVIDENCE, R.I., Dec. 8, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study ...

Read More
More Press Releases
⬆️